CI vs LRCX · P/E 2.4, rev $140.16B vs P/E 71, rev $23.23B
Cigna Corp (CI) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported CI revenue for 2026-06-30 was $140.16B. Net income was $3.31B. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. Revenue was up 26.0% from 2025-06-29 to 2026-06-28. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
CI currently screens at market cap $71.62B and trailing P/E 2.4. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the CI and LRCX stock pages for the full models.
Not investment advice.